Search

3i Group PLC

Open

SectorIndices

4,112 0.02

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4087

Max

4159

Belangrijke statistieken

By Trading Economics

Inkomsten

942M

3B

Verkoop

1.1B

3.1B

K/W

Sectorgemiddelde

7.894

26.361

EPS

3.09

Dividendrendement

1.77

Winstmarge

96.389

Werknemers

223

EBITDA

1.1B

3B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+10.61% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.77%

9.30%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

48M

40B

Vorige openingsprijs

4111.98

Vorige sluitingsprijs

4112

Nieuwssentiment

By Acuity

17%

83%

2 / 30 Rangschikking in Indices

3i Group PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 mei 2025, 08:15 UTC

Winsten
Belangrijke Marktbewegers

3i Group Shares Fall After Softer Net Asset Value Result

8 apr 2025, 05:27 UTC

Acquisities, Fusies, Overnames

3i Group Pauses Sale of Applaws Cat-Food Maker on U.S. Tariffs, Bloomberg Says, Citing Sources

24 jul 2025, 06:09 UTC

Winsten

3i Group: Focus on Actively Managing Portfolio, Remain Cautious on Pricing for New Investment

24 jul 2025, 06:09 UTC

Winsten

3i Group: Resilient Performance from Majority of Remaining Private Equity Portfolio

24 jul 2025, 06:09 UTC

Winsten

3i Group 1Q Foreign Exchange Translation Gain GBP392M

24 jul 2025, 06:04 UTC

Winsten

3i Group YTD Operating EBITDA GBP980M

24 jul 2025, 06:04 UTC

Winsten

3i Group YTD Action Net Sales GBP7.34B

24 jul 2025, 06:03 UTC

Winsten

3i Group 1Q Total Return 7%

24 jul 2025, 06:02 UTC

Winsten

3i Group 1Q NAV/Share GBP27.11

15 mei 2025, 08:00 UTC

Winsten
Belangrijke Marktbewegers

3i Group Shares Fall After Softer Net Asset Value Result

15 mei 2025, 06:16 UTC

Winsten
Belangrijke Marktbewegers

3i Group Net Asset Value Was GBP24.61B Vs GBP20.17B

15 mei 2025, 06:15 UTC

Winsten
Belangrijke Marktbewegers

3i Group Declares Dividend of 73p

15 mei 2025, 06:15 UTC

Winsten
Belangrijke Marktbewegers

3i Group Ended Yr With Net Debt of GBP771M

15 mei 2025, 06:14 UTC

Winsten
Belangrijke Marktbewegers

3i Group Ended Yr With Liquidity of GBP1.32B

15 mei 2025, 06:14 UTC

Winsten
Belangrijke Marktbewegers

3i Group: Action Cash Balance at May 11 Was EUR427M

15 mei 2025, 06:14 UTC

Winsten
Belangrijke Marktbewegers

3i Group: Action Added 76 New Stores Over 19 Weeks

15 mei 2025, 06:13 UTC

Winsten
Belangrijke Marktbewegers

3i Group: Action LFL Sales Grew 6.8% Over 19 Weeks to May 11

15 mei 2025, 06:07 UTC

Winsten
Belangrijke Marktbewegers

3i Group Private Equity Team Invested GBP1.18B in Yr

15 mei 2025, 06:06 UTC

Winsten
Belangrijke Marktbewegers

3i Group: Action Generated a GIR of GBP4.55B

15 mei 2025, 06:03 UTC

Winsten
Belangrijke Marktbewegers

3i Group: Private Equity Business Driven Primarily by Action

15 mei 2025, 06:03 UTC

Winsten
Belangrijke Marktbewegers

3i Group Private Equity Business Gross Investment Return GBP5.11B

15 mei 2025, 06:02 UTC

Winsten
Belangrijke Marktbewegers

3i Group FY Total Return GBP5.05B

15 mei 2025, 06:00 UTC

Winsten
Belangrijke Marktbewegers

3i FY EPS GBP5.206

15 mei 2025, 06:00 UTC

Winsten
Belangrijke Marktbewegers

3i FY NAV/Shr GBP25.42

15 mei 2025, 06:00 UTC

Winsten
Belangrijke Marktbewegers

3i FY Pretax Pft GBP5.04B

15 mei 2025, 06:00 UTC

Winsten
Belangrijke Marktbewegers

3i FY Net Pft GBP5.04B

7 apr 2025, 09:51 UTC

Marktinformatie

European Alternative Asset Managers Have Indirect Exposure to Tariffs -- Market Talk

30 jan 2025, 07:10 UTC

Winsten

3i Group Well Positioned for a Strong Fincl Yr to March 31

30 jan 2025, 07:10 UTC

Winsten

3i Group Remains Cautious on Macroeconomic, Geopolitical Environment

30 jan 2025, 07:10 UTC

Winsten

3i Group: All New Countries Have Performed Ahead of Budget

3i Group PLC Prognose

Koersdoel

By TipRanks

10.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4,507.25Ā GBXĀ  10.61%

Hoogste 5,000Ā GBX

Laagste 3,650Ā GBX

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor 3i Group PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

6

Buy

3

Hold

0

Sell

Sentiment

By Acuity

2 / 30 Rangschikking in Indices

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl